SCHEMBL762153

SCHEMBL762153

Cn1c(-c2ccccc2)nc2c3ccccc3c3ccc(I)cc3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.44
KDM4E B2RXH2 5/20 0.43
HPGD P15428 5/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
ADORA2A P29274 3/20 0.40
ADORA2B P29275 3/20 0.40
ADORA3 P0DMS8 2/20 0.39
ADORA1 P30542 1/20 0.39
PI4KA P42356 1/20 0.39
PI4K2B Q8TCG2 1/20 0.39
PI4K2A Q9BTU6 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
DHODH Q02127 1/20 0.36
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36
CDK2 P24941 1/20 0.36
PLK1 P53350 1/20 0.36
BTK Q06187 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL762484 0.94 TLR7 (0.44) TLR7KDM4EHPGDMEN1KMT2A
SCHEMBL822576 0.85 HPGD (0.55) TLR7KDM4EHPGDMEN1KMT2A
SCHEMBL10084264 0.80 PDE4B (0.47) TLR7KDM4EHPGDMAPTALDH1A1
SCHEMBL762155 0.77 KDM4E (0.41) TLR7KDM4EHPGDMEN1KMT2A
SCHEMBL762055 0.77 KMT2A (0.50) TLR7KDM4EHPGDMEN1KMT2A
SCHEMBL13625405 0.76 KDM4E (0.52) TLR7KDM4EHPGDMEN1KMT2A
SCHEMBL762336 0.75 KDM4E (0.52) TLR7KDM4EHPGDMEN1KMT2A
SCHEMBL762492 0.75 HPGD (0.43) TLR7KDM4EHPGDMEN1KMT2A
SCHEMBL764064 0.74 PDE4B (0.47) TLR7KDM4EHPGDMAPTALDH1A1
SCHEMBL16692180 0.74 KDM4E (0.48) TLR7KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138303-B2 Polymers BASF SE (DE) 2012-03-20 US disclosed
US-20100249349-A1 Novel Polymers UDC IRELAND LIMITED (IE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249349-A1 Novel Polymers OCIAD2, OCIAD1, SLCO4C1 TLR7 610/4885KDM4E 3738/4885HPGD 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.